Work

Genes Brca1 E Brca2 Como Biomarcadores Em Carcinomas Mamários Caninos – Revisão De Literatura

Year: 2024
Type: article
Abstract: Canine mammary carcinomas are the most commonly diagnosed neoplasm in unneutered female dogs and are the second most frequently found neoplasm among all neoplasms in dogs. As observed in breast tumors in humans, malignant mammary tumors in dogs have a high incidence of morbidity and mortality in affected animals. In addition to the epidemiological similarity with data found in the human literature on mammary neoplasms, canine mammary tumors also have high histopathological and pathophysiological similarity. Canine mammary carcinomas have a multifactorial development, which may be associated with the breed, age, castration status of the animal, and genetic factors.The BRCA1 and BRCA2 genes are two genes that, when mutated, are of great importance in forming breast tumors in humans and dogs.These are genes with an essential function in maintaining genomic stability. Due to the high similarity, using human biomarkers within veterinary medicine becomes possible. Due to the high similarity, using human biomarkers within veterinary medicine becomes possible. Mutations in the BRCA1 and BRCA2 genes are targets for use as well-defined and established biomarkers for breast and cervix tumors in women. Their high use is relevant in veterinary medicine, as is observed in the human literature. With this review, it is highlighted that the potential of using the BRCA1 and BRCA2 genes as biomarkers for canine mammary carcinomas based on existing studies is clear. However, more studies addressing this topic are still needed.
Language: Portuguese
Subfield: Small Animals
Field: Veterinary
Open Access status: diamond
OpenAlex ID: W4402742425
FWCI:
Cites: 38
Cited by:
Related to: 10